Will molecular jackhammers have at least 50% tumour-free efficacy in Phase 2 clinical trials?
Salud y medicinaOne-Off1aManifold MarketsSin KYCDatos de resolución verificadosCalibración aceptableAviso de calidad de datosDatos de la fuente degradados
Datos del 26 oct 2026, 5:41 UTC · política pm-quality-4
Pronóstico comunitario actualNo 80%
Pronosticadores
10
Tipo de pregunta
binary
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Datos de mercado
Actualizado hace 7 horas
Desactualizado31 dic 23, 16:21 UTC2 ene 28, 7:59 UTC
Tendencias
Reglas
See the paper Molecular Jackhammers Eradicate Cancer Cells By Vibronic-Driven Action in the journal Nature Chemistry https://twitter.com/burny_tech/status/1741300258406031421/photo/1
- If at the end date, I confirm that clinical trials are actively moving forward, the end date will be extended.
- Market will resolve early if I find out that researchers have decided that they are not moving forward.
- (reworded Jan 3, 2024)
